Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14887,802,1.43 [1.28-1.60],2.2500111203548591e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19588,52,1.84 [1.31-2.60],0.000506807662196
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,20588,540,1.32 [1.16-1.50],2.081506536864012e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,21758,253,1.38 [1.15-1.65],0.0003989569280776
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,21758,253,1.38 [1.15-1.65],0.0003989569280776
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18237,1421,1.21 [1.11-1.32],2.540009576368812e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,21085,682,1.58 [1.40-1.77],1.2418346419133208e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21059,656,1.55 [1.37-1.74],4.600180547683412e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,18084,1268,1.20 [1.09-1.31],0.0001453936041679
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,17984,1168,1.19 [1.08-1.31],0.0004986247392789
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Any mental disorder,19743,669,1.25 [1.11-1.40],0.0002342884354896
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Neurological diseases,19702,1293,1.21 [1.11-1.32],2.24846658788052e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other sleep disorders,21664,235,1.53 [1.28-1.84],4.210340243162182e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Sleep apnoea,22554,184,1.52 [1.24-1.87],6.278352562741495e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22880,70,1.81 [1.33-2.46],0.00015045074546
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",20405,70,1.91 [1.41-2.58],3.275697405343926e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,15714,3695,1.18 [1.11-1.26],6.168687194361607e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, essential",16578,2415,1.25 [1.16-1.34],7.044530543072097e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertension,16624,2461,1.26 [1.17-1.36],4.5743971269364503e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14269,106,1.71 [1.31-2.22],7.096402593982575e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20608,1640,1.25 [1.15-1.35],9.102488426211016e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Angina pectoris,19889,921,1.24 [1.12-1.37],5.653367096516921e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21874,332,1.33 [1.13-1.56],0.0004684455581854
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22262,720,1.33 [1.19-1.49],4.268204894484085e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19459,491,1.37 [1.20-1.56],3.2529519184242342e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20343,1399,1.27 [1.16-1.38],8.512113926059564e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22307,167,1.44 [1.16-1.79],0.0008327959707206
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18150,1977,1.17 [1.09-1.26],2.0795748241054063e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22320,272,1.38 [1.16-1.64],0.0002917908642718
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22317,269,1.38 [1.16-1.64],0.0003459039055616
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,20810,838,1.21 [1.09-1.35],0.0004033713489152
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Asthma,15827,652,1.28 [1.14-1.45],4.882945283461492e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15496,652,1.30 [1.15-1.46],2.570529187336263e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15817,642,1.30 [1.15-1.46],2.911486142639948e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15488,5479,1.10 [1.05-1.17],0.000400063555544
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,17844,2333,1.21 [1.13-1.30],8.323700513171076e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,20524,298,1.55 [1.32-1.82],5.482628087897551e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Acute renal failure,20557,73,1.66 [1.24-2.24],0.0007244250006462
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,20573,89,1.91 [1.48-2.45],5.375284537694524e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,20574,90,1.68 [1.28-2.20],0.0001832844209507
